The role of DNA methylation in the disorders of bone metabolism

Osteoporosis is one of multifactorial diseases, it develops from interactions between the genetic component and the environment. However, the universal epigenetic markers of osteoporosis are not yet defined. Finding the risk factors will predict the risk of osteoporosis at the preclinical stage, help define the course and severity of the disease, and develop preventive measures based on them to reduce the risk of fractures. Expanding knowledge in the field of bone biology, especially in the genetics of osteoporosis and osteoimmunology, showed that osteoporosis is a disease that occurs not only due to hormonal or mechanical disorders, but also as a clinically and genetically heterogeneous disease, and there are still unknown pathogenetic links in its structure. Decreases in bone mass and matrix mineralization as well as changes in bone microarchitecture can have different pathogenetic patterns of development and, moreover, there are unknown links of the pathogenesis of osteoporosis. It is possible that DNA methylation is one of these links and a mechanism for epigenetic regulation of gene expression. Evidence exists that this mechanism alongside regulatory miRNAs and post-translational modifications makes a significant contribution to the central processes of bone remodeling; however, the results of various studies vary greatly, and, therefore, there is a need to understand the significance of the accumulated data and to make them consistent. The purpose of this review is to compile and systematize data on the role of DNA methylation in bone metabolism in normal and pathological conditions, in the formation of osteoporosis, and to assess achievements and trends in this field of research and technologies for studying DNA methylation.

osteoporosis, epigenetics, DNA methylation, bone mineral density, fractures

1. Vanyushin B.F. Epigenetics today and tomorrow. Vavilovskii Zhurnal Genetiki i Selektsii = Vavilov Journal of Genetics and Breeding. 2013;17(4/2):805-832. (in Russian)

2. Grebennikova T.A., Belaya Z.E., Rozhinskaya L.Y., Mel’nichenko G.A., Dedov I.I. Epigenetic aspects of osteoporosis. Vestnik Rossiyskoy Akademii Meditsinskikh Nauk = Annals of the Russian Academy of Medical Sciences. 2015;70(5):541-548. https://doi.org/10.15690/ vramn.v70.i5.1440. (in Russian)

3. Skryabin N.A., Kashevarova A.A., Denisov E.V., Lebedev I.N. Methods of DNA methylation analysis: potential and limitations of their application in oncology. Sibirskii Onkologicheskii Zhurnal = Siberian Journal of Oncology. 2013;6:64-60. (in Russian)

4. Filina Yu.V., Gabdulkhakova A.G., Arleyevskaya M.I. The methods of analysis of DNA methylation. Biokhimiya = Biochemistry. 2012; 8:15-18. (in Russian)

5. Allis C.D., Jenuwein T., Reinberg D. (Eds.) Epigenetics. New York: Cold Spring Harbor Laboratory Press, 2007. (Russ. ed.: Ellis S.D., Dzhenyuveyn T., Reynberg D. (red.) Epigenetika. Moscow: Tekhnosfera Publ., 2010. (in Russian))

6. Baccarelli A. Techniques for epigenetic analysis. How to apply them to human and epidemiology studies. 2018. Available at https://cdn1.sph.harvard.edu/wp-content/uploads/sites/1291/2012/11/JacksonTutorial.pdf

7. Cheishvili D., Parashar S., Mahmood N., Arakelian A., Kremer R., Goltzman D., Szyf M., Rabbani S.A. Identification of an epigenetic signature of osteoporosis in blood DNA of postmenopausal women. J. Bone Miner. Res. 2018;1-34. https://doi.org/10.1002/jbmr.3527.

8. Cho Y.D., Yoon W.J., Kim W.J., Woo K.M., Baek J.H., Lee G., Ku Y., van Wijnen A.J., Ryoo H.M. Epigenetic modifications and canonical wingless/int-1 class (WNT) signaling enable transdifferentiation of nonosteogenic cells into osteoblasts. J. Biol. Chem. 2014;289(29): 20120-20128. https://doi.org/10.1074/jbc.M114.558064.

9. Colin D., Sanjay K.G., Raymond Y. Analysis of DNA methylation by pyrosequencing. Methods Mol. Biol. 2016;1343:249-264. https://doi.org/10.1007/978-1-4939-2963-4_19.

10. Del Real A., Perez-Campo F.M., Fernandez A.F., Sanudo C., Ibarbia C.G., Perez-Nunez M.I., Criekinge W.V., Braspenning M., Alonso M.A., Fraga M.F., Riancho J.A. Differential analysis of genome-wide methylation and gene expression in mesenchymal stem cells of patients with fractures and osteoarthritis. Epigenetics. 2017; 12(2):113-122. https://doi.org/10.1080/15592294.2016.1271854.

11. Delgado-Calle J., Sanudo C., Bolado A., Fernandez A.F., Arozamena J., Pascual-Carra M.A., Rodriguez-Rey J.C., Fraga M.F., Bonewald L., Riancho J.A. DNA methylation contributes to the regulation of sclerostin expression in human osteocytes. J. Bone Miner. Res. 2012;27(4):926-937. https://doi.org/10.1002/jbmr.1491.

12. Ghayor C., Weber F.E. Epigenetic regulation of bone remodeling and its impacts in osteoporosis. Int. J. Mol. Sci. 2016;17(8):E1446. https://doi.org/10.3390/ijms17091446.

13. Gupta R., Nagarajan A., Wajapeyee N. Advances in genome-wide DNA methylation analysis. BioTechniques. 2010;49(4):3-11. https://doi.org/10.2144/000113493.

14. Harvey N., Dennison E., Cooper C. Osteoporosis: a lifecourse approach. J. Bone Miner. Res. 2014;29(9):1917-1925. https://doi.org/10.1002/jbmr.2286.

15. Hussmann D., Hansen L.L. Methylation-Sensitive High Resolution Melting (MS-HRM). Methods Mol. Biol. 2018;1708:551-571. https://doi.org/10.1007/978-1-4939-7481-8_28.

16. Ku J.L., Jeon Y.K., Park J.G. Methylation-specific PCR. Methods Mol. Biol. 2011;791:23-32. https://doi.org/10.1007/978-1-61779-316-5_3.

17. Kurdyukov S., Bullock M. DNA methylation analysis: choosing the right method. Biology. 2016;5(1):3. https://doi.org/10.3390/biology5010003.

18. Lee J.Y., Lee Y.M., Kim M.J., Choi J.Y., Park E.K., Kim S.Y., Lee S.P., Yang J.S., Kim D.S. Methylation of the mouse DIx5 and Osx gene promoters regulates cell type-specific gene expression. Mol. Cell. 2006;22(2):182-188.

19. Li P., Demirci F., Mahalingam G., Demirci C., Nakano M., Meyers B.C. An integrated workflow for DNA methylation analysis. J. Genet. Genomics. 2013;40(5):249-260. https://doi.org/10.1016/j.jgg.2013.03.010.

20. Li X., Zhang Y., Kang H., Liu W., Liu P., Zhang J., Harris S.E., Wu D. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J. Biol. Chem. 2005;280(20):19883-19887. https://doi.org/10.1074/jbc.M413274200.

21. Marini F., Cianferotti L., Brandi M.L. Epigenetic mechanisms in bone biology and osteoporosis: Can they drive therapeutic choices? Int. J. Mol. Sci. 2016;17(8):1329. https://doi.org/10.3390/ijms17081329.

22. Moore L.D., Le T., Fan G. DNA methylation and its basic function. Neuropsychopharmacology. 2013;38(1):23-28. https://doi.org/10.1038/npp.2012.112.

23. Morris J.A., Tsai P.C., Joehanes R., Zheng J., Trajanoska K., Soerensen M., Forgetta V., Castillo-Fernandez J., Frost M., Spector T.D., Christensen K., Christiansen L., Rivadeneira F., Tobias J., Evans D., Kiel D.P., Hsu Y.H., Richards J.B., Bell J.T. Epigenome-wide association of DNA methylation in whole blood with bone mineral density. J. Bone Miner. Res. 2017;32(8):1644-1650. https://doi.org/10.1002/jbmr.3148.

24. Moskalev A.A., Vaiserman A. (Eds.). Epigenetics of Aging and Longevity. London: Acad. Press, 2018. Olkhov-Mitsel E., Zdravic D., Kron K. Novel multiplex MethyLight protocol for detection of DNA methylation in patient tissues and bodily fluids. Sci. Rep. 2014;4:4432. https://doi.org/10.1038/srep04432.

25. Reppe S., Datta H., Gautvik K.M. The Influence of DNA methylation on bone cells. Curr. Genomics. 2015;16(6):384-392. https://doi.org/10.2174/1389202916666150817202913.

26. Reppe S., Lien T.G., Hsu Y.H., Gautvik V.T., Olstad O.K., Yu R., Bakke H.G., Lyle R., Kringen M.K., Glad I.K., Gautvik K.M. Distinct DNA methylation profiles in bone and blood of osteoporotic and healthy postmenopausal women. Epigenetics. 2017;12(8):674687. https://doi.org/10.1080/15592294.2017.1345832.

27. Rojas A., Aguilar R., Henriquez B., Lian J.B., Stein J.L., Stein G.S., van Wijnen A.J., van Zundert B., Allende M.L., Montecino M. Epigenetic control of the bone-master Runx2 gene during osteoblast-lineage commitment by the histone demethylase JARID1B/ KDM5B. J. Biol. Chem. 2015;290(47):28329-28342. https://doi.org/10.1074/jbc.M115.657825.

28. Sozen T., Ozışık L., Başaran N.C. An overview and management of osteoporosis. Eur. J. Rheumatol. 2017;4(1):46-56. https://doi.org/10.5152/eurjrheum.2016.048.

29. Epub 2016 Dec 30. Susan E.C., Jurgen D., Nancy S.G. A real-time PCR assay for DNAmethylation using methylation-specific blockers. Nucleic Acids Res. 2004;32(1):e10. https://doi.org/10.1093/nar/gnh008.

30. Tarantino U., Iolascon G., Cianferotti L., Masi L., Marcucci G., Giusti F., Marini F., Parri S., Feola M., Rao C., Piccirilli E., Zanetti E.B., Cittadini N., Alvaro R., Moretti A., Calafiore D., Toro G., Gimigliano F., Resmini G., Brandi M.L. Clinical guidelines for the prevention and treatment of osteoporosis: summary statements and recommendations from the Italian Society for Orthopaedics and Traumatology. J. Orthop. Traumatol. 2017;18(Suppl.1):3-36. https://doi.org/10.1007/s10195-017-0474-7.

31. Tarfiei G., Noruzinia M., Soleimani M., Kaviani S., Mahmoodinia M.M., Farshdousti Hagh M., Pujol P. ROR2 promoter methylation change in osteoblastic differentiation of mesenchymal stem cells. Cell J. 2011;13(1):11-15.

32. Tu K.N., Lie J.D., Wan C.K.V., Cameron M., Austel A.G., Nguyen J.K., Van K., Hyun D. Osteoporosis: A review of treatment options. Phys. Ther. 2018;43(2):92-104.

33. Wojdacz T.K., Dobrovic A. Methylation-sensitive high resolution melting (MS-HRM): A new approach for sensitive and high-throughput assessment of methylation. Nucleic Acids Res. 2007;35(6):e41. https://doi.org/10.1093/nar/gkm013.

34. Wong H.L., Byun H.M., Kwan J.M., Campan M., Ingles S.A., Laird P.W., Yang A.S. Rapid and quantitative method of allele-specific DNA methylation analysis. BioTechniques. 2006;41(6):734739. https://doi.org/10.2144/000112305.

35. Yi-an C., Mathieu L., Sanaa C., Darci T.B., Daria G., Brent W.Z., Steven G., Thomas J.H., Rosanna W. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetic. 2013;8(2):203-209. https://doi.org/10.4161/epi.23470.

36. Zhang D., Li Q., Rao L., Yi B., Xu Q. Effect of 5-Aza-2ʹ-deoxycytidine on odontogenic differentiation of human dental pulp cells. J. Endod. 2015;41(5):640-645. https://doi.org/10.1016/j.joen.2014.12.006.

37. Zhang J.G., Tan L.J., Xu C., Hao H., Qing T., Yu Z., Chuan Q., XiangDing C., Hong-Wen D. Integrative analysis of transcriptomic and epigenomic data to reveal regulation patterns for BMD variation. PLoS One. 2015;10(9):e0138524. https://doi.org/10.1371/journal.pone.0138524.